November 25, 2025Neil Klompas, CEO and President of Augurex, was featured on the Progress, Potential, and Possibilities Podcast, hosted by Dr. Ira Pastor.

🎧 Listen to the full episode:

In the episode “Ending Diagnostic Delays in Autoimmune Conditions,” Neil discusses how innovative biomarkers and tools like SPINEstat® (Anti-14-3-3eta Multiplex test) can help address the long diagnostic delays associated with axial spondyloarthritis (axSpA), particularly in early stages, where symptoms overlap with mechanical back pain.

Neil highlights how SPINEstat® supports clinicians in distinguishing axSpA – an inflammatory autoimmune condition impacting the lower back and spine – from mechanical back pain, a common challenge that contributes to prolonged diagnostic timelines. The test also works alongside established markers such as CRP and HLA-B27, helping provide clearer early evidence of inflammatory disease and supporting more confident clinical evaluation.

The conversation emphasizes the growing value of biomarker-based testing in helping clinicians identify inflammatory back pain earlier, improve diagnostic accuracy, and support timely patient triage and treatment in axSpA.